{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to ODIN Biotech, a Texas corporation, having a place of business in Dallas, Texas, to practice the inventions embodied in the patents and patent applications belonging to the patent family having HHS Reference Number E-008-2004/0. The exclusive license is one which qualifies under the Start-Up License Agreement program which is in place from October 1, 2011 through September 30, 2012. Specific details regarding the individual patents or patent applications which belong to this patent family are set forth in the table below:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2012/05/03/2012-10636.html","cfr_references":[],"citation":"77 FR 26304","comment_url":null,"comments_close_on":"2012-05-18","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before May 18, 2012 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2012-10636","effective_on":null,"end_page":26304,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2012/05/03/2012-10636.xml","html_url":"https://www.federalregister.gov/documents/2012/05/03/2012-10636/prospective-grant-of-exclusive-license-development-of-ocular-therapeutics-utilizing-the-peptide-c16y","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2012-10636?publication_date=2012-05-03","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2012-05-03/2012-10636/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":84,"last_updated":"2026-09-21 18:15:06 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2012-05-03/pdf/2012-10636.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2012-10636.pdf?1335963124","publication_date":"2012-05-03","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2012/05/03/2012-10636.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2012-05-23T08:06:27Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":26304,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of Ocular Therapeutics Utilizing the Peptide C16Y and Related Peptides","toc_doc":"Development of Ocular Therapeutics Utilizing the Peptide C16Y and Related Peptides","toc_subject":"Prospective Grant of Exclusive License:","topics":[],"type":"Notice","volume":77}